BLFS Biolife Solutions Dashboard

BioLife Solutions, Inc. engages in the development, manufacture and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.

Company profile

Ticker

BLFS

Exchange

NASDAQ

Website

biolifesolutions.com/

CEO

Michael Rice

Incorporated

Delaware

Location

Washington

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Electromedical & Electrotherapeutic Apparatus

Medtronic • Varian Medical Systems • Conmed • Natus Medical • Masimo • LivaNova • Outset Medical • Fonar • Cutera • Inmode ...

Former names

CRYOMEDICAL SCIENCES INC

SEC CIK

0000834365

Corporate docs

Articles of Incorporation & Bylaws

IRS number

943076866

BLFS stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping

24 Mar 21

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 23)

12 Health Care Stocks Moving In Tuesday's Intraday Session

23 Mar 21

Stocks That Hit 52-Week Highs On Tuesday

23 Mar 21

During Tuesday's morning trading, 67 companies set new 52-week highs.

Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2021

23 Mar 21

The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO

23 Mar 21

Press releases

Pro users get this 30m faster

BioLife Solutions Appoints Two New Independent Board Directors

6 Apr 21

BOTHELL, Wash., April 6, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ:BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products

Stirling Ultracold to Merge with BioLife Solutions, the Leader in Gene and Cell Therapy Bioproduction Tools and Services

22 Mar 21

COLUMBUS, Ohio, March 22, 2021 /PRNewswire/ -- Stirling Ultracold, an Ohio-based manufacturer and provider of the most energy efficient, sustainable ultra-low temperature (ULT) biorepositories has entered into a

BioLife Solutions Announces Fourth Quarter and Full Year 2020 Financial Results

22 Mar 21

BOTHELL, Wash., March 22, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ:BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products

Stirling Ultracold Announces Merger Agreement with BioLife Solutions to Further Support Life-Science Industry with Expertise in Ultra-Low Temperature Storage

22 Mar 21

BioLife Solutions to Acquire Stirling Ultracold in an All-Stock Merger

22 Mar 21

Calendar

31 Mar 21

13 Apr 21

31 Dec 21

Financial summary

Financial statements Chart BLFS financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	90.46M	90.46M	90.46M	90.46M	90.46M	90.46M
Cash burn (monthly)	6.18M	(positive/no burn)	1.8M	59.17K	(positive/no burn)	(positive/no burn)
Cash used (since last report)	21.24M	n/a	6.18M	203.31K	n/a	n/a
Cash remaining	69.22M	n/a	84.28M	90.25M	n/a	n/a
Runway (months of cash)	11.2	n/a	46.9	1525.4	n/a	n/a

Beta Read what these cash burn values mean

Recent insider trades

BLFS insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
8 Apr 21	Marcus Schulz	Common Stock	Sell	Dispose S	No	No	35.77	224	8.01K	39,795
8 Apr 21	Rice Michael	Common Stock	Sell	Dispose S	No	Yes	35.32	11,461	404.8K	262,527
8 Apr 21	Rice Michael	Common Stock	Option exercise	Aquire M	No	No	1.64	11,461	18.8K	273,988
8 Apr 21	Rice Michael	Employee Stock Option Common Stock	Option exercise	Dispose M	No	No	1.64	11,461	18.8K	183,382
1 Apr 21	Greef Roderick De	Common Stock	Sell	Dispose S	No	No	36.53	3,855	140.82K	182,316
1 Apr 21	Greef Roderick De	Common Stock	Option exercise	Aquire M	No	No	0	9,932	0	186,171
1 Apr 21	Rice Michael	Common Stock	Sell	Dispose S	No	No	36.53	10,149	370.74K	262,527
1 Apr 21	Rice Michael	Common Stock	Option exercise	Aquire M	No	No	0	26,154	0	272,676
1 Apr 21	Aby J. Mathew	Common Stock	Sell	Dispose S	No	No	36.53	4,020	146.85K	200,981
1 Apr 21	Aby J. Mathew	Common Stock	Option exercise	Aquire M	No	No	0	10,358	0	211,339

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

BLFS institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

73.9% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	125	103	+21.4%
Opened positions	36	32	+12.5%
Closed positions	14	10	+40.0%
Increased positions	28	40	-30.0%
Reduced positions	45	18	+150.0%

13F shares	Current	Prev Q	Change
Total value	1.65B	725.72M	+126.8%
Total shares	24.2M	22.09M	+9.5%
Total puts	52.8K	7.8K	+576.9%
Total calls	101.2K	43.8K	+131.1%
Total put/call ratio	0.5	0.2	+193.0%

Largest owners	Shares	Value	Change
Casdin Capital	7.44M	$296.79M	+27.4%
Wasatch Advisors	1.34M	$53.3M	-22.2%
Vanguard	1.28M	$51.03M	+9.3%
BLK Blackrock	1.23M	$49.17M	+10.9%
Marshall Wace	1.16M	$46.34M	NEW
Ranger Investment Management	989.51K	$39.47M	-12.7%
AMP Ameriprise Financial	916.88K	$36.58M	+1.0%
Royce & Associates	845.12K	$33.71M	0.0%
Russell Investments	840.64K	$33.55M	-5.8%
TimesSquare Capital Management	516.1K	$20.59M	-1.5%

Largest transactions	Shares	Bought/sold	Change
Casdin Capital	7.44M	+1.6M	+27.4%
Marshall Wace	1.16M	+1.16M	NEW
Park West Asset Management	0	-966.05K	EXIT
Tower House Partners	473.1K	+473.1K	NEW
Jennison Associates	449.57K	+449.57K	NEW
Millennium Management	108.39K	-403.43K	-78.8%
Wasatch Advisors	1.34M	-380.67K	-22.2%
DB Deutsche Bank AG - Registered Shares	74.85K	-319.35K	-81.0%
STT State Street	474.53K	+270.2K	+132.2%
Light Street Capital Management	265K	+265K	NEW

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Abbott, accuracy, administer, advanced, Aebersold, alter, antitrust, Aramark, basket, Belimed, biopharma, Biostorage, budget, burdensome, calibrated, cap, CGT, checking, children, coaching, companywide, customary, directionally, distancing, domestic, dropped, dynamic, embedded, eventual, feedback, fewer, filer, GCI, GE, hospital, hypothetical, imposition, incorrectly, infection, inspection, instrument, jeopardizing, lab, leave, lowest, machinery, main, maker, mandated, MCG, merge, merged, moment, month, NaN, opposite, outlook, overhang, PanTHERA, payoff, pendency, permissible, perpetual, physically, portrayed, premier, prepaid, progression, prolonged, proposition, receipt, recession, reinforce, repayable, Rescue, resumed, rolling, Sarah, scenario, Schulz, SciSafe, segregated, short, situation, Southwest, specimen, spite, staying, steeply, strain, subsided, symptom, transmissible, transmission, uncured, underwriter, underwriting, Undiscovered, unemployment, unprecedented, unwanted, vertical, virulent, waiting, waived, whistleblower, workforce, worn

Removed: amend, barrier, certificate, classification, comparability, deficit, delivered, designate, detection, deteriorate, discourage, distributor, email, enhanced, entry, freely, fundamental, history, inadequate, incorporation, interested, investee, landlord, largely, Lessor, open, pertain, phone, premium, prevailing, redeemed, registering, representation, restated, retrospective, secured, summarized, takeover, tradable, transparency, turn, unchanged, unsolicited

From filing 10-K 2020 FY